Founding Dean, University of Ottawa Faculty of Medicine

Dr. Jacques Bradwejn trained in medicine at the University of Sherbrooke and in psychiatry at McGill University. He completed a research fellowship in psychopharmacology at McGill University and in neuropsychopharmacology at the University of Montreal. Dr. Bradwejn has also completed the Wharton Certificate of Professional Development at the Wharton School, University of Pennsylvania, and has been a member of the Wharton Fellows Program.

Before serving as Dean, Dr. Bradwejn served as Chair of the Department of Psychiatry of the University of Ottawa and as Psychiatrist-in-Chief at the Royal Ottawa Hospital, positions he has held since January 1998, and as Head of Psychiatry of The Ottawa Hospital since January 1999. He has also held positions at McGill University as Associate Professor of Psychiatry and at the University of Toronto as Professor of Psychiatry.

Dr. Bradwejn has been actively involved in psychiatric and mental health research. His main research interest has been in the field of anxiety disorders for which he has gained an international reputation. He was the first to hypothesize a role for the neuropeptide cholecystokinin (CCK) in the etiology of panic attacks in humans. He also carries out research on the integration of biological and psychological approaches in the treatment of anxiety disorders and approaches used by Complementary Medicines.

He has published over 170 articles and book chapters, presented at more than 400 scientific and educational conferences and made over 350 educational media interventions.

As Dean of the Faculty of Medicine at the University of Ottawa, a top ranking Canadian Faculty in research, education and innovation, he is credited with the creation of an MD/PhD Program, an institute for innovation in medical devices (MDI2), a School of Epidemiology, Public Health and Preventative Medicine, a Department of Innovation in Medical Education, a Program of Medicine and the Humanities and one of the largest medical simulation centers in North America (uOSSC).

Dr. Bradwejn was Chair of the Board of Directors of the Association of Faculties of Medicine of Canada (AFMC) from 2012 to 2014.


Dr. GuoqiangCHEN

Founding Dean, SJTUSM

Professor Chen receivedhis PhD in Hematology from Shanghai Second Medical University (currently Shanghai Jiao Tong University School of Medicine) in 1996. He worked as the visiting scholar at the Institute of Hematology, Saint-Louis Hospital, Paris, in 1997 and visiting assistant professor in the Department of Medicine, Mount-Sinai Medical Center, New York,from 1999 to 2001. He returned to China in 2001 and was appointed as the director of the Departmentof Pathophysiology at the Shanghai Jiao Tong University School of Medicine, where he and his colleagues made great contributionsto leukemia research.

Professor Chen has been devoting his efforts to investigate cellular and molecular mechanisms of leukemogenesis, leukemic cell differentiation and apoptosis, the functional genomics of cancer, and proteomics with the identification of drug targets to induce leukemic cell differentiation. In the past 15 years, he has made important contributions to make arsenic trioxide,a drugusedworldwideto effectively treat acute promyelocytic leukemia (APL), a unique subtype of acute myeloid leukemia.


In July 2007, he was appointed as the Vice Chancellor of the Shanghai Jiao Tong University School of Medicine, and was promoted to Chancellor in October 2010. Later, Professor Chen was appointed as the Vice President of Shanghai Jiao Tong University in December 2010. 

Professor Chen is also the associate chief editorChinese Journal of Cancer, ActaPhysiologicaSinica, the International Journal ofPathology and Clinical Medicine, and editor of the Chinese Journal of CancerBiotherapy andtheChinese Journal of Cancer Prevention and Treatment.He is alsoa reviewer forBlood, Cancer Res, Leukemia, JBC, Oncogene, Cell Death and Differentiation, Biochemical Pharmacology, Apoptosis, Oncology, BioTechnique, International J Cancer, Hematologica, and other journals. In addition, Professor Chen is very active in various associations. He is a member of the American Society of Hematology, the American Society of Molecular Biology & Biochemistry, and the American Society of Chemistry. He is chairman of theShanghai Society of Physiology, vice chairman of the Shanghai Society of Biochemistry and Molecular Biology, and member of the standing committee for the Chinese Association of Pathophysiology and theChinese Association of Biochemistry and Molecular Biology. 



Executive Dean, OSJSM

Dr. Li Shao was trained in medicine at Shanghai Second Medical Universityfor her M.D. and MSc.in hematology. She obtained her PhDin Pediatrics at Shanghai Jiao Tong University School of Medicine (SJTUSM).


Before serving as the Executive Dean of the Ottawa-Shanghai Joint School of Medicine (since 2015) and the Chief physician of the Allergy Department at theRenji Hospital (since 2014), she has been the Vice-Dean of Renji Clinical School, SJTUSM since 2010. She was the Director of the Education Affairs Office of Renji Clinical School from 2008 to 2010andthe Chief physician of the Respiratory Department at Renji Hospitalfrom 2002 to 2014. She is also a member of the Shanghai Society for Immunology and the Shanghai Medical Association of Allergy SpecialistsCommittee.


As a clinician, Dr. Shao has rich clinical experiences. She has mastered the diagnosis and treatment of routine respiratory diseases. Since 1994,she has taken part in ward and clinic works. Having taught for fifteen years as a clinical teacher, she mainly undertakes the teaching of English classes of medicine. Every year,she undertakes works in the respiratory field, including on pneumonia, respiratory failure, interstitial lung disease, sarcoidosis, pleural effusion and lung cancer. Today,Dr. Shaoparticipates in educational reform projects, specifically in PBL and CBL teaching methods.


Dr. Shao has been actively involved in researching the allergic asthma mechanism, specifically the relationship between cytokine and asthma. For the past several years, she has taken part in several funded research programs from the Health Ministry of China and the Education Ministry of Shanghai, including a study on the mechanism for the natural remission of asthmatics at puberty. Dr. Shao is nowinterested in studying the relationship between regulatory T cells and allergic asthma. She has also conducted research onthe changes of T cells in asthmatics.